COMPARISM BETWEEN ONCE DAILY AND TWICE DAILY LPV/RTR CO-ADMINISTERED WITH TENOFOVIR AND EMTRICITOBIN AMONG HIV INFECTED PATIENTS DURING MUSLIM RAMADA
Not Applicable
- Conditions
- HIV/AIDS
- Registration Number
- PACTR201007000226131
- Lead Sponsor
- Dr, Habib A. G.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
age above 18 years
- clinically stable
-patint should be on Tenofovir + Emtricytobin+ Lopinavir/ritonavir.
-patient that consented.
Exclusion Criteria
-Less than 18 year
-patient on other ARV regimen
-patient that refuse to consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tolerability(Presence or Abscence of adverse drug effects);Laboratory monitoring(Lipid profile, Kidney function test, haematocrit);Therapeutic drug monitoring;Adherence
- Secondary Outcome Measures
Name Time Method Effectiveness(Viral load, CD4 count)